Plasmapheresis in acute multiple sclerosis: Rationale and results
โ Scribed by Peter C. Dau
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 557 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0733-2459
No coin nor oath required. For personal study only.
โฆ Synopsis
Acute multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS). As listed in Table I, the lesions (plaques) are infiltrated first by perivascular and then by parenchymal T lymphocytes with a CD4' over CD8' cell type pre-Address reprint requests to
๐ SIMILAR VOLUMES
Plasmapheresis as a treatment for multiple sclerosis (MS) has been a subject of controversy since its original use in this disorder in 1979 11-31. The rationale for the use of plasmapheresis is that MS presumably is an autoimmune disease with evidence for the presence of anti-myelin antibodies 14-61
Interferons (IFN) are biological molecules with antiviral, antiproliferative, and immunomodulatory actions. Plasmapheresis (PP) combined with IFN therapy in 24 multiple sclerosis (MS) patients was associated with a rapid increase in detectable IFN levels. We describe the presence of a detectable fac